Description

Cizolirtine Citrate, Ethanamine, N,n-Dimethyl-2-[(1-Methyl-1H-Pyrazol-5-Yl)Phenylmethoxy]-, 2-Hydroxy-1,2,3-Propanetricarboxylate is a high-purity pharmaceutical intermediate and research chemical. This compound is significant for its role as a key building block in the synthesis of advanced active pharmaceutical ingredients (APIs) and for pharmacological research. It is primarily needed by pharmaceutical manufacturers, contract research organizations (CROs), and academic research institutions focused on developing new therapeutic agents.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of complex drug molecules and active pharmaceutical ingredients (APIs).
• Pharmacological Research: Used as a reference standard or investigational compound in preclinical studies to understand biological pathways and mechanisms of action.
• Analytical Standard: Serves as a high-purity standard for method development, validation, and quality control testing in analytical laboratories (HPLC, LC-MS).
• Chemical Synthesis: Employed in organic and medicinal chemistry research for the development of novel chemical entities and structure-activity relationship (SAR) studies.
• Biochemical Research: Utilized in biochemical assays and as a tool compound for target identification and validation in drug discovery pipelines.

Basic Information

Product Name	Cizolirtine Citrate, Ethanamine, N,n-Dimethyl-2-[(1-Methyl-1H-Pyrazol-5-Yl)Phenylmethoxy]-, 2-Hydroxy-1,2,3-Propanetricarboxylate
CAS No.	142155-44-0
Molecular Formula	C22H29N3O8
Molecular Weight	463.48 g/mol
Synonyms	Cizolirtine Citrate; Cizolirtine citrate salt; N,N-Dimethyl-2-[(1-methyl-1H-pyrazol-5-yl)(phenyl)methoxy]ethanamine citrate; 2-[(1-Methyl-1H-pyrazol-5-yl)(phenyl)methoxy]-N,N-dimethylethanamine 2-hydroxy-1,2,3-propanetricarboxylate; UNII-3Q6K8S6A2F; 3Q6K8S6A2F; Ethanamine, N,N-dimethyl-2-[(1-methyl-1H-pyrazol-5-yl)phenylmethoxy]-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
EINECS	Contact for details

Quality Control

Our Cizolirtine Citrate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure it meets high-purity standards suitable for pharmaceutical research and development. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with every shipment to guarantee traceability and batch-to-batch consistency.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥98.0%
Water Content (KF)	≤1.0%
Residue on Ignition	≤0.1%
Heavy Metals	≤20 ppm
Related Substances (HPLC)	Total impurities ≤2.0%
Single Maximum Impurity	≤0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.